DUBLIN, Oct. 21, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vrqtzl/2016_emerging) has announced the addition of the "2016 Emerging Opportunities in the US Home/Self Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood--Business Challenges and Marketing Strategies for Suppliers--Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentat" report to their offering.
This new 175-page report provides analysis of themajor home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
- Review of the home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation and occult blood. - Five-year sales forecasts.
Competitive Assessments
- Assessments of major POC suppliers and emerging market entrants.
Companies Mentioned
- Abbott
- ADI/American Diagnostica
- Agilent Technologies
- Alere/Biosite/Inverness
- Axis-Shield
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data
- Biomerieux
- Bio-Rad
- Cepheid
- Chrono-Log
- Diagnostica Stago/Trinity Biotech
- Diamedix
- Diasorin
- Eiken Chemical
- EKF Diagnostics
- Fujirebio
- Grifols
- Helena Laboratories
- Hologic/Gen-Probe
- Horiba
- Instrumentation Laboratory
- Qiagen
- Roche
- SDIX
- Sequenom
- Siemens
- Sienco
- Sysmex
- Takara Bio
- ThermoFisher
- Tosoh
- Wako
- Zycare/Alere
For more information visit http://www.researchandmarkets.com/research/vrqtzl/2016_emerging
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article